Key result
St. Jude aortic valve replacement carries a ~37% lifetime bleeding risk in 75-year-old men.
Meta-Analysis (n=2,986)
Meta-analysis combined with microsimulation provides age-specific estimates of life expectancy and lifetime risks of thromboembolic and bleeding events after AVR with St. Jude Medical prostheses, emphasizing the need for optimal INR control.
Answers are grounded in this paper and cite their sources.
Age-specific risks highlight bleeding hazard in elderly post-AVR; extends microsimulation modeling to guide personalized anticoagulation and trials.
Aims Prognosis after aortic valve replacement (AVR) with mechanical prostheses depends on multiple inter-related factors. Investigation into these factors is complicated by limited knowledge on outcome after AVR and by the varying therapeutic ranges of International Normalized Ratio employed worldwide. Meta-analysis was combined with microsimulation to calculate evidence-based, age-specific outcomes after AVR with St. Jude Medical (SJM) prostheses (St. Jude Medical, Inc., St. Paul, MN, U.S.A.). Method and results Eight studies were included in a meta-analysis of published results of primary isolated AVR with SJM prostheses (2986 patients, 16,163 patient-years) in order to estimate the hazard of postoperative valve-related events. Using microsimulation, calculated life expectancy and event-free life expectancy were 22 and 16 years in males aged 35 years, and 7 and 5 years in males aged 75 years, respectively. Calculated lifetime risks for thromboembolic and bleeding events were 22% and 15% in males aged 35 years, and 7% and 37% in males aged 75 years, respectively. Varying thromboembolic and bleeding hazards resulted in considerable shifts in lifetime risks and deaths associated with these events. Conclusion Meta-analysis combined with microsimulation is a powerful tool with which to calculate reliable estimates of long-term prognosis, and allows detailed insight into the occurrence of valve-related events. Thromboembolism and bleeding occur frequently after AVR with mechanical prostheses and have an important impact on survival. Optimal control of International Normalized Ratio is therefore of utmost importance.
No takes yet. Share an insight, caveat, or question.
Johanna J.M. Takkenberg (2001) conducted a meta-analysis in Primary isolated aortic valve replacement (n=2,986). Aortic valve replacement with St. Jude Medical prostheses was evaluated on Postoperative valve-related events (thromboembolic and bleeding events). Aortic valve replacement with St. Jude Medical prostheses in males aged 35 and 75 years yielded lifetime risks of 22% and 7% for thromboembolic events, and 15% and 37% for bleeding events.
Synapse has enriched 10 related papers. Consider them for comparative context: